Market Research Logo

Nonalcoholicsteatohepatitis (NASH) - Pipeline Analysis

Nonalcoholicsteatohepatitis (NASH) - Pipeline Analysis

“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report also covers some of the hot targets in research for NASH treatments and NASH related biomarkers.

This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Non-alcoholic steatohepataitis (NASH) drugs market. The report also provide strategic insights on some of the molecules that are yet to be launched in the next few years. Some of the key sections covered in the report are given below:

Epidemiology

In this section, epidemiology of NASH is reviewed to understand potential significance and impact of the disease.

Global & US prevalence rates

Hot Targets, Mechanisms & Therapies

In this section, various NASH associated targets, mechanism and upcoming therapies are discussed. Also, covers novel targets in early research for NASH along with disease progression biomarkers associated with NASH (Inflammatory, apoptosis, fibrosis)

Market analysis

In market analysis section, global NASH drugs market is indicated along with the estimated Peak sales ($) of leading clinical stage drugs forecasted from 2019-2025.

Forecasting model for NASH market

NASH market dynamics

NASH Market and estimated Peak sales of 8 clinical candidates (OCA-Intercept, Aramchol-Galmed, GR-MD-02-Gilead, Cenicriviroc-Tobira, Simtuzumab-Gilead, Remo Biphasic-Avolynt, IVA 337-Inventiva Pharma, GFT505-Genfit)

NASH related deals analysis with financials (upfront, milestones and royalties)

Funding scenario in NASH market

Pipeline Analysis

Pipeline analysis was carried to get deeper insights on various treatment modalities in discovery, preclinical & development section, pipelines from major companies were identified and Potential targets were reported along with Mechanism of action, Current development status & nature of molecule. Pipeline analysis by developmental stage (Discovery to Clinical development)

Pipeline analysis by modalities

Monoclonal Antibodies pipeline analysis

RNA-therapeutics pipeline analysis

Recombinant protein pipeline analysis

Pipeline analysis by leading players & Target analysis

Drug analysis based on mechanism (Anti-Inflammatory, Anti-fibrotic & Metabolic)

Key Players Analysis

The key player’s analysis section provides an in-depth understanding of various companies working on Nonalcoholic steatohepatitis (NASH) and their Pipelines with development phase as well as understanding partnering strategies such as deals entered by the company.

Global key players overview

Global key players Pipeline data (Discovery, Pre-clinical & Clinical development)

Global key players deals (Collaborations, Licensing, Service agreements, grants, funds)


REPORT DESCRIPTION INTRODUCTION
Causes & Symptoms
Diagnosis
Unmet needs
Current therapies
HOT TARGETS, MECHANISMS & THERAPIES
Novel Disease mechanisms & therapies
Leading & hot targets of NASH
Novel targets of NASH
NASH biomarkers Genes involved in NASH
MARKET DATA
Forecasting model
Market dynamics
Market sizing
NASH Deals
Funding Scenario
PIPELINE ANALYSIS
Development stage
Leading players
Therapeutic segmentation
Target analysis
Clinical update on Phase 3 molecules
Innovative approaches
Small molecules
Pipeline
Competitive landscape Large molecules
Competitive landscape RNA-BASED THERAPY
Pipeline
Competitive landscape RECOMBINANT PROTEINS
Pipeline
Competitive landscape ANTIBODIES
Pipeline
Competitive landscape LARGE MOLECULES (UNSPECIFIED)
Pipeline
OTHER MOLECULES
Pipeline
NASH DRUG ANALYSIS BASED ON MECHANISM
MAJOR PLAYERS
Company Profiles
Overview, Pipeline & Deals
REFERENCE

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report